Assistant Professor Govt.Ayurveda college , profile picture
Uploaded byAssistant Professor Govt.Ayurveda college
PPT, PDF1,208 views

Ulcerative colitis ayurvedic view

The document outlines a clinical trial to evaluate the efficacy of piccha vasthi in alleviating symptoms of ulcerative colitis, including its definitions, etiology, clinical features, management, and treatment options from both modern and Ayurvedic perspectives. It includes details on the methodology of the research, demographics of participants, assessment criteria, and hypotheses regarding the treatment's significance. The study emphasizes the need for prompt treatment and maintenance in managing ulcerative colitis to prevent relapses.

Embed presentation

Download to read offline
A CLINICAL TRIAL TO EVALUATE THE EFFICACY OF PICCHA VASTHI IN REDUCING THE SIGNS AND SYMPTOMS OF ULCERATIVE COLITIS Simi Ravindran Dr.Simi Ravindran Assistant professor Govt.Ayurveda college Kannur simisreehari@gmail.com Wats up-9496370179
Contents Introduction Anatomy and physiology of colon Ulcerative colitis- Modern view Anatomy and physiology Ulcerative colitis -Ayurvedic perspective Drug review Methodology of research Conclusion
Anatomy • The large intestine constitutes the terminal part of the digestive system. • It is responsible for recovery of 1-1.5 l of electrolyte –rich fluid entering it. • Allow the body to maintain fluid and electrolyte balance. • Formation of low volume, solid stools, and permits less frequent defecation. • Provide environment of low oxygen tension conducive to bacterial colonization. . • Approximately 1.5 m long and capacity when filled by enema is 2L of volume, resident volume is 200 ml, and intracolonic volume is 750 ml. • Histology • Mucosa • Submucosa • Circular muscles • Longitudinal muscle • Serosa
Concentration of fecal effluent through water and electrolyte absorption Bacterial Growth Production of Vitamins & Electrolytes Muscular Action of the colon Stool Transit & Defecation Physiology
Ulcerative colitis Etymology Ulcerative: means relating to, causing, or marked by an ulcer or ulcers. Colitis: means inflammation of the colon. Defenition Ulcerative colitis is an inflammatory disorder that causes ulcers and irritation in the inner lining of the colon of the colonic mucosa, characterized by relapses and remissions.
Etiology • Genetic predisposition • Infections • Allergy • Psychosomatic illness • Environmental factors • Autoimmune diseases
Clinical feautures • Bloody diarrhea • Increased bowel frequency • Passage of mucus with stool • Abdominal cramps • Abdominal distension • Anorexia • Signs -tachycardia, fever, abdominal tenderness or distension. • malaise, weight loss Related to activity- • Apthous Ulcers • Erythema Nodosum • Finger Clubbing • Occular-conjunctivitis • Episcleritis • Iritis • Arthritis • Osteoporosis Unrelated to activity • Gallstones • Sacroiliitis • Arthralgia • Nutritional Deficiency
Ulcerative Colitis-Types Ulcerative proctitis:limited to the rectum. diarrhea, bloody stool, pain in the rectal area, and a sense of urgency to empty the bowel. Proctosigmoiditis: rectum and the sigmoid colon.diarrhea, bloody stool, cramps and pain in the rectal area, and moderate pain on the left side of the abdomen Left-sided colitis: Left-sided colitis affects the entire left side of the colon, from the rectum to splenic flexure. diarrhea, bleeding, weight loss ,loss of appetite, and sometimes severe pain on the left side of abdomen. Pancolitis: If the entire colon is affected, the term pancolitis is used ("pan" meaning total).
Establish the severity Clinical and radiological criteria table for assessing the severity of Ulcerative colitis Feature Mild Moderate severe Motions/day <4 >4-6 >6Large Rectal bleeding Small Moderate Large amounts Temperature Apyrexial Intermediate >37.8C on 2days out of 4 Pulse rate Normal Intermediate >90b.p.m Hemoglobin 11g/dl Intermediate <0.5g/dl ESR <20mm/h Intermediate >30mm/h
Establish the diagnosis Sigmoidoscopy and biopsy Colonoscopy Stool examination
Sigmoidoscopic appearances in Ulcerative colitis Mild Moderate severe Diffuse erythema Granular mucosa Intense inflammation Loss of vascular pattern Petechial hemorrhages Purulent exudates Contact bleeding Spontaneous bleeding, Discrete ulcers
Differential diagnosis Crohn's colitis Infective colitis Drug -induced colitis Microscopic colitis
Crohn's colitis Radiology- Discontinuous,asymmetrical,deep ulcers,common strictures and fistulae Histology- transmural Distribution, lymphocytes infiltrates Clinical -Bloody diarrhea is about 50%,common abdominal mass, perianal diseases
Management The principals of management are Prompt treatment of acute attacks. Maintenance therapy to reduce the relapse rate. Selection of patients for colectomy. Detection of colorectal carcinoma. Patient education is essential to ensure early presentation during relapse.
5-ASA Compounds Medications to Suppress the Immune System Surgery • standard ileostomy • continent ostomy • ileo-anal pull-through
Prognosis The pattern of relapse and remission one year after diagnosis tends to continue for any individual. 90% have intermittent activity and 50% are in remission at any one time.20% will relapse every year and 10% have continous symptoms Prolonged remission on maintance therapy occurs ,with 50- 60%remaining in remission for more than 2 years,but <5% are symptom- free for 15 years
Anatomy-Ayurvedic view Kosta Asayas Grahani Pittadhara kala Pureesha dhara kala Guda Siras Dhamni Asthi Snayu
Nidanas Atisara Grahani Agnidusti Annavaha sroto dusti Pureeshavaha sroto dusti manasika nidanas
Blood with stool-saraktha malam • Paittika atisaram(Su.u.40) • Raktartisara(ch.chi 19) • Raktaja pravahika(Ma.NI3/22) • Raktarsas(Ma.NI4/16) • Pittarsas(Ma.NI4/16) • Adhogaraktapitta(As.Hr.chi2/8)
Ulceration of the colon Guda paka • Paittikagrahani(As.Hr) • Rakta vaha sroto dusti (CH.Su)
Looser stools Drava /sithila varchas (Vatika and Paittika grahani) Abdominal cramps Udara soola Vatika grahani(Su) Anorexia Annadvesha - Kaphaja atisara(Ch.Ch.19) Abdominal distension Admanam Vatika grahani Heart burn Hrit daha Pittaja grahani
Fever.Hyperacidity & Upper GI Symptom Jwaram Daha, Trishna, Sweda, Shula - Pittaja atisara, Rakta atisara Pitta grahani (Ch. Chi. 19/6) Increased frequency stool Punah punah varcha (Vatikagrahani,Paittika grahani) Passage of mucus with stool Sleshasamsrishta pureesham Kaphaja Atisara (Ch. Chi. 19/7) Kaphaja grahani
Abdominal cramps Udara soola Vatika grahani(Su) Anorexia Annadvesha - Kaphaja atisara(Ch.Ch.19) Heart burn Hrit daha Pittaja grahani
Gurgling sounds in the abdomen Vayu cha Antah Kosthe Antrakujanam Vatika grahani Vatika atisara Pakvasaya gata vata kopa(Ch.Chi.19/5) Urgency of defecation Kshipra varcha prvartanam Bhaya,soka athisara
Weight loss Karsyam Vatgika grahani Loss of concentration Manasadanam (Nanatmaja roopa of vata)
Low backache Parva ruk Adhakaya rogas Pakvasaya gata vata kopa(Ch. Chi. 28/28-29) Chronicity Chirakalanubandhini Sangraha Grahani ( M.N. 4 : 13)
Diseases akin to Ulcerative colitis • Atisara :Pittaja, Raktaja, Vataja, Kaphaja Atisara. • Pravahika: (raktaja Pravahika). • Grahani : (paittika,vatika). • Pakvashayagata Vatakopa (site& adhara kaya rogas).
• Samprapthi ghatakas • Dosha- Tridosha ,raktaja • Prana Dusti (Impaired Secretion ) • Samana Dusti (Disturbed Motility) • Apana Dusti (Incomplete Evacuation) • Pachaka Pitta Dusti (Heartburn, Ulceration) • Kledaka Kapha (Stool with Mucus,pus with mucus) • Dusya- Rakta, rakta, mamsa, majja • Sadhyasadyata -yapya
• Agni -mainly Jatragni, dhatwagni, bhootagni • Srotas - Annavaha, Rasavaha, Raktavaha, Purishavaha • Sroto Dusti - Initially sanga then atipravritti • Agni - Vishamagni • Adhishthana - Mahasrotas • Udbhavasthanam-amasayam • Rogamargam-abhyantartaam • Vyaktasthanam-pakvasayam • Swabhava - Chirakari
Samprapthi nidanaas Vatha pitta kapha Incresed drava guna and sara guna of pitta Agni dusti Aharapachana hamprers Amayuktha pakva apakva misrita anna Malasanchaya in pak asaya Rakthadusti formation of vrina Punah punah sleshma samsritha raktha mala pravritti Incresed usna and teekshna guna of pitta.apana vaigunya
Treatment Nidana parivarjanam Oushadha sevanam Deepana Pachana Grahi Raktha sthambana Vatanuloma Shothahara Vedanasathapana “pakvo asakrit atisaro grahani mardavadyada Pravartate tadakarya kshipram samgrahiko vidhi”(C.D)
Pathya,apathya Pathya sevanam -Kasayarasa pradhana ahara, deepana, laghu guna yukta ahara, purana sali, vilepi,lajamanda ,small fishes,jambu phala, vilva , salooka, kapitha ,bakuji,dadima,madhu, mudga yusha, changeri, rambha pushpa, kamalakanda, Jambu, Kapittha, Takra etc. Apathyas :Rooksha ,guru ahara, virudhasana, godhooma, masha,yava, vasthuka, madhu sigru, koosmanda, tumbi, badara All saka varga, punarnava atishita Jala, dushta Jala, guru, snigdha, drava, ati ruksha, & saraka substances, viruddha bhojana, etc.
Apathya vihara Langhana,Vamana karma,Poorna visrama, Nidra, Activities making mind happy. Snana, abhyanga, avagaha, guru ,snigda bhojana, vyayama, agni santapa should be avoided by atisara rogi as per the text of Chakradatta.
Piccha vasthi Etymology Picha-means • slimy/saliva • The gum of Bombax heptaphyllum Vasthi- • See,abiding,dwelling,staying Defenition “Alpaya Matraya Niroohakhyo vastihi picchavastihi”(Aruna datta)
Indications • Pravahika • Complication of vasthi • Parisrava • Treatment of jivadana
Ingredients Dose saindhava 3 gm makshika 120 ml Madhuytastyadi taila 120 ml Mahatiktaka grutha 120 ml Salmali vrinta putapaka mixed with ksheera 240 ml Kalka of yasti and tagara 48 gm Astanga hridaya atisara chikitsa
Salmali putapaka swarasa. Atisara pravahagno raktarukpittadahaha amatisara samano raktatisaranasana….”(nighantu ratnakara) “Pakvatisarasamano hanthi ghora sa pravahika….”(madanapala nighantu) “Pravahika atisara ama kaphapittasradahanut....”(kaiya deva nighantu) “Avedanam ssampakvam deeptagne suchirothitham Nanavarmnamatisaram putapakairupacharel…”. Chakra datta2/74)-
Mahatiktaka grutham Grahani chikitsa theindication is there “pittagrahanyam tal peyam kustoktamtiktakam cha yal” .Mahatiktaka grutham is indicated in the kusta chikitsa .phala sruti includes paittika grahani.athisaras Madhuyastyadi tailam A combination of Madhura rasa drugs, mentioned in vatasonitha prakarana, having raktha prasadana and brumhana properties.The main ingredient is yastimadhu ,which is pittasamana,can used in four forms.pana,nasya,anuvasana,abhyanga.
Yastimadhu -: Botanical name- Glycyrrhiza glabraLinn Family- leguminosae Sandhaniya, Varnya, Sonitasthapana (Cu.),) Madhur,Guru, Singdha ,Madhura Vipaka, Sheeta Veerya,Effect on dosha : tridosha samana,rakta Dosha prasamana,Karma : Vrana Ropana, Daha Samana. Tagara Botanical name- Valeriana jatamansi Jones Family- Valerianaceae Rasam:madhura,tiktha,Guna:laghu,snigda,seetha, Action on doshas-tridosa nasanam,raktha dosha nasanam
Methodology of research Out line of the study • Extensive literary survey • Clinical work Selection of cases Population The population comprises of patients diagnosed of ulcerative colitis ,who satisfy the inclusion criteria.12 patients are included in the study Inclusion Criteria Ulcerative colitis patients diagnosed by colonoscopy and biopsy Age between 18-60 years Both sex are included Patient willing to participate Exclusion criteria Diseases other than ulcerative colitis Age below 18 yrs and above 60 yrs Other severe debilitating diseases Patients not willing for the study
Study design The present study is before and after study with out control.no blinding was done Time and duration of the study The total period of the study was 18 months Assessment criteria Blood with stool Assessment was done form grade ‘0’to ‘3’ according to the following criteria Passage of blood with stool • Grade 0 - no blood • Gradae1 - occasional • Grade2 - moderate amount • Grade3 - excessive amount
Passage of mucus with stool • Grade 0 - no mucus • Grade1 - occasional • Grade2 - moderate amount • Grade3 - excessive amount Increased frequency of motion(in a day) • Grade 0 - normal no of stools for this patient • Gradae1 - 1-2 /day extra stools per day • Grade2 - 3-4 extra stools per day • Grade3 - 5 or more extra stools per day Diarrhea • Grade 0 - no diarrhea • Gradae1 1-2 times • Grade2 - 5-8 • Grade3 - more than 8 times Abdominal cramps • Grade 0 - not present • Gradae1 - occasional • Grade2 - 3-4 times • Grade3 - always
Anorexia • Grade 0 - no anorexia • Gradae1 - occasional interest for diet or food • Grade2 feels hungry but could not able to take food • Grade3 - no interest for diet or food Abdominal distension • Grade 0 -no abdominal distension • Gradae1 - occasional • Grade2 - after taking food • Grade3 - always associated Blood Hb TC DC ESR RBS Urine • Sugar • Albumin • Deposits Stool • Color • Consistency • Microscopic • Occult blood • Proctoscopy
Hypothetical conclusion Null hypothesis Piccha vasthi is not significant in the reducing signs and symptoms of Ulcerative colitis. Alternate hypothesis Piccha vasthi is significant in reducing the signs and symptoms of Ulcerative colitis.
Observation analysis and interpretation The data relating to the study were conveniently segregated into four heading as follows:- Demographic data. Out of the total patients, females and males were in equal ratio. 75% of the people were married and 25% were unmarried The study reveals that 66.7% of patients are Hindus, 25% are in Christian religion and 8.3% are Muslims. While considering the socio-economic status 41.7% are from middle class 33. 3% from high class and 25% are poor class. 58.3% of the patients are from rural areas and 41.7% from urban areas. In this study, 41.7% are educated, up to high school level, 25% are graduates, 16.7% have pre degree, and 16.7% were illiterate. 66.7% of the patients underwent the study have sedentary and mental stress ,while 25% have physical exercise and 8.3% were have both physical and mental stress.
Prakriti: • Vata-Pitta Prakriti dominated -50% of the people are belonging to vatha pitta prakruti,30% were kapha pitta prakruti,20% were vath kapha prakruti.. • Half of the patients have day work, 33.3% have night work and 16.7% have irregular timings in work. • 41.7% working more than 8 hours, 33.3% working in between 6-8 hours, and 16.7% work less than 6 hours. • 75% have irregular intake of food habits and 25% regular intake of food.
• 50 % have no addiction and 25% have addiction of smoking and the rest quarter having the addiction of alcohol. • 58.3% have moderate exercise and 41.7% have heavy exercise. • Data related to chronicity reveals that half of the patients have chronicity between 5-10 years ,16.7% have 10-15 years and 33.3% have 0-5 years of duration. • The symptoms of Ulcerative colitis precipitated by emotional stress accompanied by food in 50% of the patients .In 16.7% food is the causative factor for aggravating symptoms, and in 33.3% ,emotional stress is the aggravating factor. • 58.3% have feeling of anxiety and 41.7% , not have feeling of anxiety. • Initial insomnia presnt is 50% of the patients and absent in rest.
• Among 12 patients 91.7% having score-grade 2 in rectal bleeding, and 8.3% of grade 1 • 58.3% have grade 1 in passage of mucus, and 41.7% have grade 2 that is moderate amount of mucus passing with stool. • 50% have grade 2 and 50 % have grade 3 in bowel frequency • 50%have grade 2 and 50 % have grade 3 in bowel frequency • 50%have grade 2 and 50 % have grade 3 in abdominal cramps. • Among 12 patients 58.3% have grade 2 and 41.7 have grade 3 in severity of anorexia • 58.3% having grade 1 and 41.7 % having grade 2 in abdominal distension
Effectiveness of treatment Blood with stool, BT,AT and Follow up The p value is <0.01 which shows that the treatment is highly significant in reducing the blood with stool. After 30 days of follow up mean difference with before vasthi is 1.5 and paired ‘t’ value is 10 and p value is <0.01 shows that the treatment is highly significant in the follow up period. 0.0 0.5 1.0 1.5 2.0 2.5 BV AV 15th day 30th day Mean score
Passage of mucus with stool The p value is <0.01 which shows that the treatment is highly significant in reducing the mucus with stool. After 30 days of follow up, mean difference with before vasthi is 0.83 and paired ‘t’ value is 4 and p value is <0.01 shows that the treatment is significance in the follow up period. 0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6 BV AV 15th day 30th day Mean score
Incresed frequency of bowel The p value is <0.01 which shows that the treatment is significant in reducing increased frequency of bowel immediately after vasthi and during follow up. 0.0 0.5 1.0 1.5 2.0 2.5 3.0 BV AV 15th day 30th day Mean score
Diarrhoea Before treatment mean was 1.5 in diarrhoea treatment, and after vasthi it was 0 with mean difference of 1.5 with paired ‘t”test value 10. The p value is <0.01 .after follow uo mean is 0.5 with mean difference of 1 and paired 't'value is 8.1 The p value is <0.01.shows that the treatment is highly significant immediate after vasthi and follow up 0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6 BV AV 15th day 30th day Mean score
Abdominal cramps Before treatment mean was 1.5 in diarrhoea treatment, and after vasthi it was 0 with mean difference of 1.5 with paired ‘t”test value 10. The p value is <0.01 .after follow uo mean is 0.5 with mean difference of 1 and paired 't'value is 8.1 The p value is <0.01.shows that the treatment is highly significant immediate after vasthi and follow up 0.0 0.5 1.0 1.5 2.0 2.5 3.0 BV AV 15th day 30th day Mean score
Anorexia In anorexia mean value before treatment was 2.42 nd immediately aftervasthi , it was0.08 with mean difference 2.33 shows paired t value 12.4 the p value is <0.01. After follow up mean is 0.08 with mean difference 2.33 which shows paired t value of 12.4, the p value is <0.01 which shows that the treatment is significant in reducing anorexia immediately after vasthi and follow up period. 0.0 0.5 1.0 1.5 2.0 2.5 3.0 BV AV 15th day 30th day Mean score
Abdominal distension The p value is <0.01 which shows that the treatment is highly significant in reducing the treatment of blood with stool. After 30 days of follow up mean is 0.50 with mean difference of 0.92 and paired ‘t’ value is 6.2 and p value is <0.01 shows that the treatment is significance in the follow up period. 0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6 BV AV 15th day 30th day Mean score
Effectiveness of treatment on Hb The p value is <0.05, after follow up the mean is 11.02 with a mean difference of 1.29 and pair ‘t’test shows the value 5.8. The p value is <0.01 which shows that the treatment is significant in increasing Hb level. 9.0 9.5 10.0 10.5 11.0 11.5 BV AV 15th day 30th day Mean score
Effectiveness of increase in retention time of sneha vasthi The p value is P<0.01. The statistical analysis shows that the retention time is significantly increasing. 0.0 50.0 100.0 150.0 200.0 250.0 300.0 350.0 400.0 450.0 Day 1 Day 2 Day 4 Day 6 Day 8 Mean score
Table Effectiveness of increase in retention time of PV The retention time of first Piccha vasthi with mean of 3.5 and mean difference of 1.5 with second Piccha vasthi ‘t’ test shows 4.64 and p values p<0.01. on fifth day mean is 4.9 and with third day the difference is 1.8 on seventh day paired t is 4.25. the p value p<0.01. the statistical analysis show that the retention time is statistically increasing. 0.0 1.0 2.0 3.0 4.0 5.0 6.0 Day 3 Day 5 Day 7 Mean score
conclusion The main conclusions derived from the study are In the present study alternate hypothesis were significantly satisfied. The present study Piccha vasthi corrects the following symptoms after vasthi and after follow up is proved to be highly significant. • Presence of blood in stool • presence of mucous in the stool • diarrhoea . • abdominal cramps • Anorexia • abdominal distension • frequency of stools per day
• With the statistical analysis highly significant improvement were observed in the heamatological values in Hb levels. • The retension time is incresing because of getting asayabala after vasthi • Ahara paka ,dathu parinama and dathu posana are the main processes deranged in the disease,which emaciated the patient more and more with the progression of the disease. • Mahatiktaka grutha present in the Picchavasthi of aid excellent ropana as well as daha prasamana property,enhancing the general guna of the Piccha vasthi.

More Related Content

PPSX
Galaganda (Goitre)
byvdsriram
 
PPTX
Abyantar Snehapan
byesha sharma
 
PPTX
MODE OF ACTION OF BASTI KARMA
bymadhu ranjan
 
PDF
Pariharya vishay
byDr.Shalu Jain
 
PPTX
CONCEPT OF BASTI
byDrRaoSahebDeshmukh
 
PDF
Prameha chikitsa
byAaptashri Ayurved & Panchakarma Clinic,Pune
 
PPTX
HRIDROGA.pptx
byविकास महर्जन
 
PPTX
kshata ksheena.pptx
byshruthipanambur
 
Galaganda (Goitre)
byvdsriram
 
Abyantar Snehapan
byesha sharma
 
MODE OF ACTION OF BASTI KARMA
bymadhu ranjan
 
Pariharya vishay
byDr.Shalu Jain
 
CONCEPT OF BASTI
byDrRaoSahebDeshmukh
 
Prameha chikitsa
byAaptashri Ayurved & Panchakarma Clinic,Pune
 
HRIDROGA.pptx
byविकास महर्जन
 
kshata ksheena.pptx
byshruthipanambur
 

What's hot

PPTX
VATARAKTA.pptx
byAkshay Shetty
 
PPT
Avabahuka chikitsa dr prashanth a s
bydrprashanth
 
PPTX
Pakshaghate virechanam
byYadu Gopan Valiyaparambil
 
PPSX
Asthi Kshaya - Asthi sousirya (osteoporosis)
byvdsriram
 
PPSX
Karsya & Mamsasosha
byvdsriram
 
PPTX
CLINICAL ASPECTS OF VIRECHANA AND ITS MODE OF ACTION
byPanchakarma Sdmcahhassan
 
PPTX
Understanding of MUTARGHATA w.s.r to B.P.H
byDrNeharu Mandoli
 
PPTX
Mutrashmari
byविकास महर्जन
 
PPTX
panchakarma in tamaka swasa
bySaurav Verma
 
PPTX
Amavata by Dr.Swatika Sharma
byDr.Swatika Sharma
 
PPTX
ARSHA - Dravya Prayoga.pptx
byAditi Gandhi
 
PPTX
Samsarjana krama .pptx
byAkshay Shetty
 
PPTX
Pradhana karma of Vamana
byAkshay Shetty
 
PPTX
Shoola in Ayurveda Dr Akshay Shetty.pptx
byAkshay Shetty
 
PPTX
CLINICAL ASPECTS OF BASTI AND ITS MODE OF ACTION
byPanchakarma Sdmcahhassan
 
PPTX
Panchakarma in vatarakta
bySaurav Verma
 
PPSX
Sthaulya roga (obesity) for class ayurveda
byvdsriram
 
PDF
Satwavajaya Chikitsa in Unmada
bySachin Bagali
 
PPTX
Siravyadha
byAkshay Shetty
 
PPT
Vatavyadhi Chikitsa PPT for ayurveda bams.ppt
byYogesh Kumre
 
VATARAKTA.pptx
byAkshay Shetty
 
Avabahuka chikitsa dr prashanth a s
bydrprashanth
 
Pakshaghate virechanam
byYadu Gopan Valiyaparambil
 
Asthi Kshaya - Asthi sousirya (osteoporosis)
byvdsriram
 
Karsya & Mamsasosha
byvdsriram
 
CLINICAL ASPECTS OF VIRECHANA AND ITS MODE OF ACTION
byPanchakarma Sdmcahhassan
 
Understanding of MUTARGHATA w.s.r to B.P.H
byDrNeharu Mandoli
 
Mutrashmari
byविकास महर्जन
 
panchakarma in tamaka swasa
bySaurav Verma
 
Amavata by Dr.Swatika Sharma
byDr.Swatika Sharma
 
ARSHA - Dravya Prayoga.pptx
byAditi Gandhi
 
Samsarjana krama .pptx
byAkshay Shetty
 
Pradhana karma of Vamana
byAkshay Shetty
 
Shoola in Ayurveda Dr Akshay Shetty.pptx
byAkshay Shetty
 
CLINICAL ASPECTS OF BASTI AND ITS MODE OF ACTION
byPanchakarma Sdmcahhassan
 
Panchakarma in vatarakta
bySaurav Verma
 
Sthaulya roga (obesity) for class ayurveda
byvdsriram
 
Satwavajaya Chikitsa in Unmada
bySachin Bagali
 
Siravyadha
byAkshay Shetty
 
Vatavyadhi Chikitsa PPT for ayurveda bams.ppt
byYogesh Kumre
 

Similar to Ulcerative colitis ayurvedic view

PDF
Ulcerative colitis and its ayurvedic corelation
bydeswalkaruna77
 
PDF
Ulcerative colitis and its ayurvedic corelation
bydeswalkaruna77
 
PPTX
A CLINICAL TRIAL TO EVALUATE THE EFFFICACY OF PICCHAVASTHI IN REDUCING SIGNS ...
byAssistant Professor Govt.Ayurveda college
 
PPTX
GIT_Examination_Lecture_BAMS_Enhanced.pptx
byamskhn2024
 
PPTX
Ulcerative Colitis by Kushal.pptx. A very knowledgeable presentation pn the t...
bysmmalik1414
 
PPTX
GIT_Examination_Lecture_BAMS_integrated with modern.pptx
byamskhn2024
 
PPTX
Natural treatment for Ulcerative Colitis 
byPlanet Ayurveda
 
PPTX
Atisar and According to Ayurveda and modern
byramrahim8111
 
PPT
GASTROINTESTINAL TRACT DISORDERS KRCHN.ppt
byombasojackson
 
PPT
GASTROINTESTINAL TRACT DISORDERS KRCHN.ppt
byombasojackson
 
PPTX
Role of yoga as a therapy in digestive.pptx
byGarimaSetia7
 
PDF
Ulcerative colitis
byPramukh Homoeopathic Clininc
 
PPTX
Clinical aspects of virechana & mode of action
bySuraj Kumbar
 
PPTX
Colitis and homeopathy treatment
byPranav Pandya
 
PPTX
basu ppt AMJARIRNA CASE DISCUSSION.new one.pptx
bybasavaraj kadamudimatha
 
PPTX
Inflammatory bowel disease(IBD) BY DR SAMI KUMAR SHAH -1.pptx
bySamiShah20
 
PDF
pancreatitis
byDr jithesh madhavan
 
PPTX
Grahani_Ayurveda_Presentation.pptx slide
byalokpandey186502
 
PPTX
Ulcerative colitis by Dr. Ali Hasan
byS M Ali Hasan
 
PPTX
Amlapitta(Acid peptic Disease) Ayurvedic managment strategies
byDr. Nayan Mehar
 
Ulcerative colitis and its ayurvedic corelation
bydeswalkaruna77
 
Ulcerative colitis and its ayurvedic corelation
bydeswalkaruna77
 
A CLINICAL TRIAL TO EVALUATE THE EFFFICACY OF PICCHAVASTHI IN REDUCING SIGNS ...
byAssistant Professor Govt.Ayurveda college
 
GIT_Examination_Lecture_BAMS_Enhanced.pptx
byamskhn2024
 
Ulcerative Colitis by Kushal.pptx. A very knowledgeable presentation pn the t...
bysmmalik1414
 
GIT_Examination_Lecture_BAMS_integrated with modern.pptx
byamskhn2024
 
Natural treatment for Ulcerative Colitis 
byPlanet Ayurveda
 
Atisar and According to Ayurveda and modern
byramrahim8111
 
GASTROINTESTINAL TRACT DISORDERS KRCHN.ppt
byombasojackson
 
GASTROINTESTINAL TRACT DISORDERS KRCHN.ppt
byombasojackson
 
Role of yoga as a therapy in digestive.pptx
byGarimaSetia7
 
Ulcerative colitis
byPramukh Homoeopathic Clininc
 
Clinical aspects of virechana & mode of action
bySuraj Kumbar
 
Colitis and homeopathy treatment
byPranav Pandya
 
basu ppt AMJARIRNA CASE DISCUSSION.new one.pptx
bybasavaraj kadamudimatha
 
Inflammatory bowel disease(IBD) BY DR SAMI KUMAR SHAH -1.pptx
bySamiShah20
 
pancreatitis
byDr jithesh madhavan
 
Grahani_Ayurveda_Presentation.pptx slide
byalokpandey186502
 
Ulcerative colitis by Dr. Ali Hasan
byS M Ali Hasan
 
Amlapitta(Acid peptic Disease) Ayurvedic managment strategies
byDr. Nayan Mehar
 

Recently uploaded

PPTX
adrenaldiseases.faciomaxillarysurgery.pptx
byDr Kingshika Joylin
 
PDF
Ppt bls basic life support for respiratory arrest developed by devansh and n...
bydevanshshankhwar05
 
PPTX
Speech language Pathology-1 (lecture 1).pptx
byDr Zonera Khalid PT
 
PDF
Prosthetic Solutions Cranio-Maxillo-Facial
byDavide Decesari
 
PDF
MIndsets in Career of Emergency Medicine
byChing-Hsing Lee
 
PDF
Lenvatinib Tablets: Uses, Benefits, Diseases Treated & Availability in the Ph...
byLetsMeds
 
PDF
Microencapsulation and their Application in Novel Drug Delivery
byGOKULAKRISHNAN S
 
PPTX
Phytochemical Analysis And Antimicrobial Screening Studies Of Calotropis Giga...
bySoukat Garain
 
PDF
Ibrutinib 140 mg Capsule Treatment Guide
byLetsMeds
 
PPTX
HD catheters, what do we need to know 2025 updated.pptx
byJAFAR ALSAID
 
PPTX
MEDICAL RESEARCH UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx
byDHANASHREE KOLHEKAR
 
PDF
Technodelics.tech l Consciousness Hacking Through Light, Sound & Vibration l ...
byVladislav Solodkiy
 
PPTX
Foundations of Pharmaceutical Quality Assurance and Quality Management System...
byDr. Smita Kumbhar
 
PDF
Antibiotics: Cephalosporins & Monobactams.pdf
byPrerana Jadhav
 
PPT
Next-Generation Solutions to Optimize Glioma Care: Applying The Latest Eviden...
byPVI, PeerView Institute for Medical Education
 
PDF
Comprehensive survey of median nerve-Prof.Dr.N.Mugunthan.pdf
byKanyakumari Medical Mission Research Center, Muttom
 
PPTX
INTELLIGENCE (PSYCHOLOGY IN NURSING).pptx
byPahari Sharma
 
PPTX
Holistic Oral Care- Danta Davana and Jihwa nilekhana in Ayurveda: Classical ...
bySudha Sumathy
 
PDF
classification & denaturation and structural -functional relationship of Prot...
byDr. Santhosh Kumar. N
 
PPTX
On DNA sequence chimeras, DNA sequence misannotation and interpretation issue...
byChristenRuneStensvol
 
adrenaldiseases.faciomaxillarysurgery.pptx
byDr Kingshika Joylin
 
Ppt bls basic life support for respiratory arrest developed by devansh and n...
bydevanshshankhwar05
 
Speech language Pathology-1 (lecture 1).pptx
byDr Zonera Khalid PT
 
Prosthetic Solutions Cranio-Maxillo-Facial
byDavide Decesari
 
MIndsets in Career of Emergency Medicine
byChing-Hsing Lee
 
Lenvatinib Tablets: Uses, Benefits, Diseases Treated & Availability in the Ph...
byLetsMeds
 
Microencapsulation and their Application in Novel Drug Delivery
byGOKULAKRISHNAN S
 
Phytochemical Analysis And Antimicrobial Screening Studies Of Calotropis Giga...
bySoukat Garain
 
Ibrutinib 140 mg Capsule Treatment Guide
byLetsMeds
 
HD catheters, what do we need to know 2025 updated.pptx
byJAFAR ALSAID
 
MEDICAL RESEARCH UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx
byDHANASHREE KOLHEKAR
 
Technodelics.tech l Consciousness Hacking Through Light, Sound & Vibration l ...
byVladislav Solodkiy
 
Foundations of Pharmaceutical Quality Assurance and Quality Management System...
byDr. Smita Kumbhar
 
Antibiotics: Cephalosporins & Monobactams.pdf
byPrerana Jadhav
 
Next-Generation Solutions to Optimize Glioma Care: Applying The Latest Eviden...
byPVI, PeerView Institute for Medical Education
 
Comprehensive survey of median nerve-Prof.Dr.N.Mugunthan.pdf
byKanyakumari Medical Mission Research Center, Muttom
 
INTELLIGENCE (PSYCHOLOGY IN NURSING).pptx
byPahari Sharma
 
Holistic Oral Care- Danta Davana and Jihwa nilekhana in Ayurveda: Classical ...
bySudha Sumathy
 
classification & denaturation and structural -functional relationship of Prot...
byDr. Santhosh Kumar. N
 
On DNA sequence chimeras, DNA sequence misannotation and interpretation issue...
byChristenRuneStensvol
 

Ulcerative colitis ayurvedic view

  • 1.
    A CLINICAL TRIALTO EVALUATE THE EFFICACY OF PICCHA VASTHI IN REDUCING THE SIGNS AND SYMPTOMS OF ULCERATIVE COLITIS Simi Ravindran Dr.Simi Ravindran Assistant professor Govt.Ayurveda college Kannur simisreehari@gmail.com Wats up-9496370179
  • 2.
    Contents Introduction Anatomy and physiologyof colon Ulcerative colitis- Modern view Anatomy and physiology Ulcerative colitis -Ayurvedic perspective Drug review Methodology of research Conclusion
  • 3.
    Anatomy • The largeintestine constitutes the terminal part of the digestive system. • It is responsible for recovery of 1-1.5 l of electrolyte –rich fluid entering it. • Allow the body to maintain fluid and electrolyte balance. • Formation of low volume, solid stools, and permits less frequent defecation. • Provide environment of low oxygen tension conducive to bacterial colonization. . • Approximately 1.5 m long and capacity when filled by enema is 2L of volume, resident volume is 200 ml, and intracolonic volume is 750 ml. • Histology • Mucosa • Submucosa • Circular muscles • Longitudinal muscle • Serosa
  • 4.
    Concentration of fecaleffluent through water and electrolyte absorption Bacterial Growth Production of Vitamins & Electrolytes Muscular Action of the colon Stool Transit & Defecation Physiology
  • 5.
    Ulcerative colitis Etymology Ulcerative: meansrelating to, causing, or marked by an ulcer or ulcers. Colitis: means inflammation of the colon. Defenition Ulcerative colitis is an inflammatory disorder that causes ulcers and irritation in the inner lining of the colon of the colonic mucosa, characterized by relapses and remissions.
  • 6.
    Etiology • Genetic predisposition •Infections • Allergy • Psychosomatic illness • Environmental factors • Autoimmune diseases
  • 7.
    Clinical feautures • Bloodydiarrhea • Increased bowel frequency • Passage of mucus with stool • Abdominal cramps • Abdominal distension • Anorexia • Signs -tachycardia, fever, abdominal tenderness or distension. • malaise, weight loss Related to activity- • Apthous Ulcers • Erythema Nodosum • Finger Clubbing • Occular-conjunctivitis • Episcleritis • Iritis • Arthritis • Osteoporosis Unrelated to activity • Gallstones • Sacroiliitis • Arthralgia • Nutritional Deficiency
  • 8.
    Ulcerative Colitis-Types Ulcerative proctitis:limitedto the rectum. diarrhea, bloody stool, pain in the rectal area, and a sense of urgency to empty the bowel. Proctosigmoiditis: rectum and the sigmoid colon.diarrhea, bloody stool, cramps and pain in the rectal area, and moderate pain on the left side of the abdomen Left-sided colitis: Left-sided colitis affects the entire left side of the colon, from the rectum to splenic flexure. diarrhea, bleeding, weight loss ,loss of appetite, and sometimes severe pain on the left side of abdomen. Pancolitis: If the entire colon is affected, the term pancolitis is used ("pan" meaning total).
  • 9.
    Establish the severity Clinicaland radiological criteria table for assessing the severity of Ulcerative colitis Feature Mild Moderate severe Motions/day <4 >4-6 >6Large Rectal bleeding Small Moderate Large amounts Temperature Apyrexial Intermediate >37.8C on 2days out of 4 Pulse rate Normal Intermediate >90b.p.m Hemoglobin 11g/dl Intermediate <0.5g/dl ESR <20mm/h Intermediate >30mm/h
  • 10.
    Establish the diagnosis Sigmoidoscopyand biopsy Colonoscopy Stool examination
  • 11.
    Sigmoidoscopic appearances in Ulcerativecolitis Mild Moderate severe Diffuse erythema Granular mucosa Intense inflammation Loss of vascular pattern Petechial hemorrhages Purulent exudates Contact bleeding Spontaneous bleeding, Discrete ulcers
  • 12.
    Differential diagnosis Crohn's colitis Infectivecolitis Drug -induced colitis Microscopic colitis
  • 13.
    Crohn's colitis Radiology- Discontinuous,asymmetrical,deep ulcers,commonstrictures and fistulae Histology- transmural Distribution, lymphocytes infiltrates Clinical -Bloody diarrhea is about 50%,common abdominal mass, perianal diseases
  • 15.
    Management The principals ofmanagement are Prompt treatment of acute attacks. Maintenance therapy to reduce the relapse rate. Selection of patients for colectomy. Detection of colorectal carcinoma. Patient education is essential to ensure early presentation during relapse.
  • 16.
    5-ASA Compounds Medications toSuppress the Immune System Surgery • standard ileostomy • continent ostomy • ileo-anal pull-through
  • 17.
    Prognosis The pattern ofrelapse and remission one year after diagnosis tends to continue for any individual. 90% have intermittent activity and 50% are in remission at any one time.20% will relapse every year and 10% have continous symptoms Prolonged remission on maintance therapy occurs ,with 50- 60%remaining in remission for more than 2 years,but <5% are symptom- free for 15 years
  • 18.
  • 19.
  • 20.
    Blood with stool-sarakthamalam • Paittika atisaram(Su.u.40) • Raktartisara(ch.chi 19) • Raktaja pravahika(Ma.NI3/22) • Raktarsas(Ma.NI4/16) • Pittarsas(Ma.NI4/16) • Adhogaraktapitta(As.Hr.chi2/8)
  • 21.
    Ulceration of thecolon Guda paka • Paittikagrahani(As.Hr) • Rakta vaha sroto dusti (CH.Su)
  • 22.
    Looser stools Drava /sithilavarchas (Vatika and Paittika grahani) Abdominal cramps Udara soola Vatika grahani(Su) Anorexia Annadvesha - Kaphaja atisara(Ch.Ch.19) Abdominal distension Admanam Vatika grahani Heart burn Hrit daha Pittaja grahani
  • 23.
    Fever.Hyperacidity & UpperGI Symptom Jwaram Daha, Trishna, Sweda, Shula - Pittaja atisara, Rakta atisara Pitta grahani (Ch. Chi. 19/6) Increased frequency stool Punah punah varcha (Vatikagrahani,Paittika grahani) Passage of mucus with stool Sleshasamsrishta pureesham Kaphaja Atisara (Ch. Chi. 19/7) Kaphaja grahani
  • 24.
    Abdominal cramps Udara soola Vatikagrahani(Su) Anorexia Annadvesha - Kaphaja atisara(Ch.Ch.19) Heart burn Hrit daha Pittaja grahani
  • 25.
    Gurgling sounds inthe abdomen Vayu cha Antah Kosthe Antrakujanam Vatika grahani Vatika atisara Pakvasaya gata vata kopa(Ch.Chi.19/5) Urgency of defecation Kshipra varcha prvartanam Bhaya,soka athisara
  • 26.
    Weight loss Karsyam Vatgika grahani Lossof concentration Manasadanam (Nanatmaja roopa of vata)
  • 27.
    Low backache Parva ruk Adhakayarogas Pakvasaya gata vata kopa(Ch. Chi. 28/28-29) Chronicity Chirakalanubandhini Sangraha Grahani ( M.N. 4 : 13)
  • 28.
    Diseases akin toUlcerative colitis • Atisara :Pittaja, Raktaja, Vataja, Kaphaja Atisara. • Pravahika: (raktaja Pravahika). • Grahani : (paittika,vatika). • Pakvashayagata Vatakopa (site& adhara kaya rogas).
  • 29.
    • Samprapthi ghatakas •Dosha- Tridosha ,raktaja • Prana Dusti (Impaired Secretion ) • Samana Dusti (Disturbed Motility) • Apana Dusti (Incomplete Evacuation) • Pachaka Pitta Dusti (Heartburn, Ulceration) • Kledaka Kapha (Stool with Mucus,pus with mucus) • Dusya- Rakta, rakta, mamsa, majja • Sadhyasadyata -yapya
  • 30.
    • Agni -mainlyJatragni, dhatwagni, bhootagni • Srotas - Annavaha, Rasavaha, Raktavaha, Purishavaha • Sroto Dusti - Initially sanga then atipravritti • Agni - Vishamagni • Adhishthana - Mahasrotas • Udbhavasthanam-amasayam • Rogamargam-abhyantartaam • Vyaktasthanam-pakvasayam • Swabhava - Chirakari
  • 31.
    Samprapthi nidanaas Vatha pitta kapha Increseddrava guna and sara guna of pitta Agni dusti Aharapachana hamprers Amayuktha pakva apakva misrita anna Malasanchaya in pak asaya Rakthadusti formation of vrina Punah punah sleshma samsritha raktha mala pravritti Incresed usna and teekshna guna of pitta.apana vaigunya
  • 32.
    Treatment Nidana parivarjanam Oushadha sevanam Deepana Pachana Grahi Rakthasthambana Vatanuloma Shothahara Vedanasathapana “pakvo asakrit atisaro grahani mardavadyada Pravartate tadakarya kshipram samgrahiko vidhi”(C.D)
  • 33.
    Pathya,apathya Pathya sevanam -Kasayarasapradhana ahara, deepana, laghu guna yukta ahara, purana sali, vilepi,lajamanda ,small fishes,jambu phala, vilva , salooka, kapitha ,bakuji,dadima,madhu, mudga yusha, changeri, rambha pushpa, kamalakanda, Jambu, Kapittha, Takra etc. Apathyas :Rooksha ,guru ahara, virudhasana, godhooma, masha,yava, vasthuka, madhu sigru, koosmanda, tumbi, badara All saka varga, punarnava atishita Jala, dushta Jala, guru, snigdha, drava, ati ruksha, & saraka substances, viruddha bhojana, etc.
  • 34.
    Apathya vihara Langhana,Vamana karma,Poornavisrama, Nidra, Activities making mind happy. Snana, abhyanga, avagaha, guru ,snigda bhojana, vyayama, agni santapa should be avoided by atisara rogi as per the text of Chakradatta.
  • 35.
    Piccha vasthi Etymology Picha-means • slimy/saliva •The gum of Bombax heptaphyllum Vasthi- • See,abiding,dwelling,staying Defenition “Alpaya Matraya Niroohakhyo vastihi picchavastihi”(Aruna datta)
  • 36.
    Indications • Pravahika • Complicationof vasthi • Parisrava • Treatment of jivadana
  • 37.
    Ingredients Dose saindhava 3gm makshika 120 ml Madhuytastyadi taila 120 ml Mahatiktaka grutha 120 ml Salmali vrinta putapaka mixed with ksheera 240 ml Kalka of yasti and tagara 48 gm Astanga hridaya atisara chikitsa
  • 38.
    Salmali putapaka swarasa. Atisarapravahagno raktarukpittadahaha amatisara samano raktatisaranasana….”(nighantu ratnakara) “Pakvatisarasamano hanthi ghora sa pravahika….”(madanapala nighantu) “Pravahika atisara ama kaphapittasradahanut....”(kaiya deva nighantu) “Avedanam ssampakvam deeptagne suchirothitham Nanavarmnamatisaram putapakairupacharel…”. Chakra datta2/74)-
  • 39.
    Mahatiktaka grutham Grahani chikitsatheindication is there “pittagrahanyam tal peyam kustoktamtiktakam cha yal” .Mahatiktaka grutham is indicated in the kusta chikitsa .phala sruti includes paittika grahani.athisaras Madhuyastyadi tailam A combination of Madhura rasa drugs, mentioned in vatasonitha prakarana, having raktha prasadana and brumhana properties.The main ingredient is yastimadhu ,which is pittasamana,can used in four forms.pana,nasya,anuvasana,abhyanga.
  • 40.
    Yastimadhu -: Botanical name-Glycyrrhiza glabraLinn Family- leguminosae Sandhaniya, Varnya, Sonitasthapana (Cu.),) Madhur,Guru, Singdha ,Madhura Vipaka, Sheeta Veerya,Effect on dosha : tridosha samana,rakta Dosha prasamana,Karma : Vrana Ropana, Daha Samana. Tagara Botanical name- Valeriana jatamansi Jones Family- Valerianaceae Rasam:madhura,tiktha,Guna:laghu,snigda,seetha, Action on doshas-tridosa nasanam,raktha dosha nasanam
  • 41.
    Methodology of research Outline of the study • Extensive literary survey • Clinical work Selection of cases Population The population comprises of patients diagnosed of ulcerative colitis ,who satisfy the inclusion criteria.12 patients are included in the study Inclusion Criteria Ulcerative colitis patients diagnosed by colonoscopy and biopsy Age between 18-60 years Both sex are included Patient willing to participate Exclusion criteria Diseases other than ulcerative colitis Age below 18 yrs and above 60 yrs Other severe debilitating diseases Patients not willing for the study
  • 42.
    Study design The presentstudy is before and after study with out control.no blinding was done Time and duration of the study The total period of the study was 18 months Assessment criteria Blood with stool Assessment was done form grade ‘0’to ‘3’ according to the following criteria Passage of blood with stool • Grade 0 - no blood • Gradae1 - occasional • Grade2 - moderate amount • Grade3 - excessive amount
  • 43.
    Passage of mucuswith stool • Grade 0 - no mucus • Grade1 - occasional • Grade2 - moderate amount • Grade3 - excessive amount Increased frequency of motion(in a day) • Grade 0 - normal no of stools for this patient • Gradae1 - 1-2 /day extra stools per day • Grade2 - 3-4 extra stools per day • Grade3 - 5 or more extra stools per day Diarrhea • Grade 0 - no diarrhea • Gradae1 1-2 times • Grade2 - 5-8 • Grade3 - more than 8 times Abdominal cramps • Grade 0 - not present • Gradae1 - occasional • Grade2 - 3-4 times • Grade3 - always
  • 44.
    Anorexia • Grade 0- no anorexia • Gradae1 - occasional interest for diet or food • Grade2 feels hungry but could not able to take food • Grade3 - no interest for diet or food Abdominal distension • Grade 0 -no abdominal distension • Gradae1 - occasional • Grade2 - after taking food • Grade3 - always associated Blood Hb TC DC ESR RBS Urine • Sugar • Albumin • Deposits Stool • Color • Consistency • Microscopic • Occult blood • Proctoscopy
  • 45.
    Hypothetical conclusion Null hypothesis Picchavasthi is not significant in the reducing signs and symptoms of Ulcerative colitis. Alternate hypothesis Piccha vasthi is significant in reducing the signs and symptoms of Ulcerative colitis.
  • 46.
    Observation analysis and interpretation Thedata relating to the study were conveniently segregated into four heading as follows:- Demographic data. Out of the total patients, females and males were in equal ratio. 75% of the people were married and 25% were unmarried The study reveals that 66.7% of patients are Hindus, 25% are in Christian religion and 8.3% are Muslims. While considering the socio-economic status 41.7% are from middle class 33. 3% from high class and 25% are poor class. 58.3% of the patients are from rural areas and 41.7% from urban areas. In this study, 41.7% are educated, up to high school level, 25% are graduates, 16.7% have pre degree, and 16.7% were illiterate. 66.7% of the patients underwent the study have sedentary and mental stress ,while 25% have physical exercise and 8.3% were have both physical and mental stress.
  • 47.
    Prakriti: • Vata-Pitta Prakritidominated -50% of the people are belonging to vatha pitta prakruti,30% were kapha pitta prakruti,20% were vath kapha prakruti.. • Half of the patients have day work, 33.3% have night work and 16.7% have irregular timings in work. • 41.7% working more than 8 hours, 33.3% working in between 6-8 hours, and 16.7% work less than 6 hours. • 75% have irregular intake of food habits and 25% regular intake of food.
  • 48.
    • 50 %have no addiction and 25% have addiction of smoking and the rest quarter having the addiction of alcohol. • 58.3% have moderate exercise and 41.7% have heavy exercise. • Data related to chronicity reveals that half of the patients have chronicity between 5-10 years ,16.7% have 10-15 years and 33.3% have 0-5 years of duration. • The symptoms of Ulcerative colitis precipitated by emotional stress accompanied by food in 50% of the patients .In 16.7% food is the causative factor for aggravating symptoms, and in 33.3% ,emotional stress is the aggravating factor. • 58.3% have feeling of anxiety and 41.7% , not have feeling of anxiety. • Initial insomnia presnt is 50% of the patients and absent in rest.
  • 49.
    • Among 12patients 91.7% having score-grade 2 in rectal bleeding, and 8.3% of grade 1 • 58.3% have grade 1 in passage of mucus, and 41.7% have grade 2 that is moderate amount of mucus passing with stool. • 50% have grade 2 and 50 % have grade 3 in bowel frequency • 50%have grade 2 and 50 % have grade 3 in bowel frequency • 50%have grade 2 and 50 % have grade 3 in abdominal cramps. • Among 12 patients 58.3% have grade 2 and 41.7 have grade 3 in severity of anorexia • 58.3% having grade 1 and 41.7 % having grade 2 in abdominal distension
  • 50.
    Effectiveness of treatmentBlood with stool, BT,AT and Follow up The p value is <0.01 which shows that the treatment is highly significant in reducing the blood with stool. After 30 days of follow up mean difference with before vasthi is 1.5 and paired ‘t’ value is 10 and p value is <0.01 shows that the treatment is highly significant in the follow up period. 0.0 0.5 1.0 1.5 2.0 2.5 BV AV 15th day 30th day Mean score
  • 51.
    Passage of mucuswith stool The p value is <0.01 which shows that the treatment is highly significant in reducing the mucus with stool. After 30 days of follow up, mean difference with before vasthi is 0.83 and paired ‘t’ value is 4 and p value is <0.01 shows that the treatment is significance in the follow up period. 0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6 BV AV 15th day 30th day Mean score
  • 52.
    Incresed frequency ofbowel The p value is <0.01 which shows that the treatment is significant in reducing increased frequency of bowel immediately after vasthi and during follow up. 0.0 0.5 1.0 1.5 2.0 2.5 3.0 BV AV 15th day 30th day Mean score
  • 53.
    Diarrhoea Before treatment meanwas 1.5 in diarrhoea treatment, and after vasthi it was 0 with mean difference of 1.5 with paired ‘t”test value 10. The p value is <0.01 .after follow uo mean is 0.5 with mean difference of 1 and paired 't'value is 8.1 The p value is <0.01.shows that the treatment is highly significant immediate after vasthi and follow up 0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6 BV AV 15th day 30th day Mean score
  • 54.
    Abdominal cramps Before treatmentmean was 1.5 in diarrhoea treatment, and after vasthi it was 0 with mean difference of 1.5 with paired ‘t”test value 10. The p value is <0.01 .after follow uo mean is 0.5 with mean difference of 1 and paired 't'value is 8.1 The p value is <0.01.shows that the treatment is highly significant immediate after vasthi and follow up 0.0 0.5 1.0 1.5 2.0 2.5 3.0 BV AV 15th day 30th day Mean score
  • 55.
    Anorexia In anorexia meanvalue before treatment was 2.42 nd immediately aftervasthi , it was0.08 with mean difference 2.33 shows paired t value 12.4 the p value is <0.01. After follow up mean is 0.08 with mean difference 2.33 which shows paired t value of 12.4, the p value is <0.01 which shows that the treatment is significant in reducing anorexia immediately after vasthi and follow up period. 0.0 0.5 1.0 1.5 2.0 2.5 3.0 BV AV 15th day 30th day Mean score
  • 56.
    Abdominal distension The pvalue is <0.01 which shows that the treatment is highly significant in reducing the treatment of blood with stool. After 30 days of follow up mean is 0.50 with mean difference of 0.92 and paired ‘t’ value is 6.2 and p value is <0.01 shows that the treatment is significance in the follow up period. 0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6 BV AV 15th day 30th day Mean score
  • 57.
    Effectiveness of treatmenton Hb The p value is <0.05, after follow up the mean is 11.02 with a mean difference of 1.29 and pair ‘t’test shows the value 5.8. The p value is <0.01 which shows that the treatment is significant in increasing Hb level. 9.0 9.5 10.0 10.5 11.0 11.5 BV AV 15th day 30th day Mean score
  • 58.
    Effectiveness of increasein retention time of sneha vasthi The p value is P<0.01. The statistical analysis shows that the retention time is significantly increasing. 0.0 50.0 100.0 150.0 200.0 250.0 300.0 350.0 400.0 450.0 Day 1 Day 2 Day 4 Day 6 Day 8 Mean score
  • 59.
    Table Effectiveness ofincrease in retention time of PV The retention time of first Piccha vasthi with mean of 3.5 and mean difference of 1.5 with second Piccha vasthi ‘t’ test shows 4.64 and p values p<0.01. on fifth day mean is 4.9 and with third day the difference is 1.8 on seventh day paired t is 4.25. the p value p<0.01. the statistical analysis show that the retention time is statistically increasing. 0.0 1.0 2.0 3.0 4.0 5.0 6.0 Day 3 Day 5 Day 7 Mean score
  • 60.
    conclusion The main conclusionsderived from the study are In the present study alternate hypothesis were significantly satisfied. The present study Piccha vasthi corrects the following symptoms after vasthi and after follow up is proved to be highly significant. • Presence of blood in stool • presence of mucous in the stool • diarrhoea . • abdominal cramps • Anorexia • abdominal distension • frequency of stools per day
  • 61.
    • With thestatistical analysis highly significant improvement were observed in the heamatological values in Hb levels. • The retension time is incresing because of getting asayabala after vasthi • Ahara paka ,dathu parinama and dathu posana are the main processes deranged in the disease,which emaciated the patient more and more with the progression of the disease. • Mahatiktaka grutha present in the Picchavasthi of aid excellent ropana as well as daha prasamana property,enhancing the general guna of the Piccha vasthi.